Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Jim Cramer Advises FirstTime Homebuyers to Expect Market Corrections and Adopt a 5050 StockIndex Strategy SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags Florida Exodus Tax Haven Loses Luster as Residents Seek Affordability Morgan Stanley Lowers Polaris Industries Price Target to 69 Citing Macroeconomic Headwinds Spirit Airlines Bankruptcy Reignites Debate Over FailingFirm Defense in Antitrust Cases Diageo Q1 2026 Earnings EPS Misses Estimates Amidst Mixed Market Sentiment HHH Q1 2026 Earnings Earnings Beat Estimates Despite Stock Decline WidePoint WYY Q1 2026 Earnings EPS Surprises Positively Revenue Not Disclosed Stock Declines 19 AnheuserBusch Inbev BUD Q1 2026 Earnings EPS Beats Estimates by 815 Amid Volume Recovery EXC Q1 2026 Earnings Slight EPS Beat Bolsters Utilitys Steady Outlook Trinity Industries TRN Under Pressure Stock Declines 461 as Key Support Nears Tempus AI Inc TEM Modestly Higher as It Holds Near Key Support Booking Holdings BKNG Surges 31 Navigating Key Resistance at 17679 Verde Clean Fuels Warrant VGASW Hovers at 004 A MicroCap Energy Play at Critical Support Hong Kong Regulatory Body Raids Local Units of Two Chinese Brokerages Report US and China Remain at Odds on Trade APEC Signals Show Retail Investors Reduce Exposure to Reliance Industries TCS and Other BlueChips in Q4 SpaceX Successfully Launches Starship Rocket on Second Attempt Advancing DeepSpace Capabilities Copa Holdings Q1 2026 Earnings Strong EPS Surprise Lifts Shares AREC Q3 2025 Earnings NarrowerthanExpected Loss Drives Positive Sentiment UUUU Q1 2026 Earnings EPS Beat Helps Shares Edge Higher Despite No Revenue Reported BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower FGSN Q1 2026 Earnings Earnings Miss Sends Notes Lower Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Focuses on Pipeline Progress